- ISIN
- US3620136586
- Issuer
- GMO
- Inception Date
- Sep 18, 1985
- Category
- Large Cap Value Equities
- Min. Investment
- $5,000,000
- Distribution Policy
- Distributing
- Asset Class
- Equity
- Asset Class Size
- Large-Cap
- Asset Class Style
- Value
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
GMUEX Performance Chart
GMO U.S. Equity Fund (GMUEX) is up 15.1% since the beginning of the year. GMUEX is currently trading at $17 per share. Investors who bought $1,000 worth of GMUEX shares 5 years ago would now be looking at an investment worth $1,900.
Loading charts...
Returns By Period
GMO U.S. Equity Fund (GMUEX) has returned 15.12% so far this year and 39.06% over the past 12 months. Looking at the last ten years, GMUEX has achieved an annualized return of 14.68%, outperforming the S&P 500 Index benchmark, which averaged 13.71% per year.
GMO U.S. Equity Fund
- 1D
- -0.18%
- 1M
- 1.15%
- YTD
- 15.12%
- 6M
- 14.02%
- 1Y
- 39.06%
- 3Y*
- 23.76%
- 5Y*
- 13.70%
- 10Y*
- 14.68%
Benchmark (S&P 500 Index)
- 1D
- -1.44%
- 1M
- -1.45%
- YTD
- 7.60%
- 6M
- 6.59%
- 1Y
- 22.24%
- 3Y*
- 19.20%
- 5Y*
- 11.54%
- 10Y*
- 13.71%
GMUEX Monthly Returns History
Based on dividend-adjusted daily data since Jan 2, 1990, GMUEX's average daily return is +0.03%, while the average monthly return is +0.54%. At this rate, an investment would double in approximately 10.7 years.
Historically, 61% of months were positive and 39% were negative. The best month was Apr 2020 with a return of +12.0%, while the worst month was Aug 1998 at -14.4%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 5 months.
On a daily basis, GMUEX closed higher 52% of trading days. The best single day was Dec 9, 2021 with a return of +14.2%, while the worst single day was Jul 1, 1997 at -17.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 3.44% | -0.47% | -4.87% | 10.46% | 6.99% | -0.53% | 15.12% | ||||||
| 2025 | 3.89% | -2.95% | -6.45% | -1.66% | 6.45% | 5.60% | 1.61% | 3.68% | 4.33% | 2.93% | 2.12% | 1.49% | 22.24% |
| 2024 | 0.77% | 5.89% | 5.20% | -5.01% | 5.71% | 1.78% | 2.32% | 0.71% | 1.33% | -0.83% | 5.52% | -3.50% | 20.97% |
| 2023 | 6.33% | -1.80% | 2.07% | 0.47% | -1.79% | 7.13% | 3.27% | -2.42% | -3.42% | -2.73% | 8.60% | 5.36% | 22.02% |
| 2022 | -4.82% | -2.35% | 2.41% | -5.71% | 1.06% | -8.16% | 8.46% | -3.89% | -8.67% | 9.67% | 6.51% | -5.72% | -12.66% |
| 2021 | 1.03% | 4.96% | 6.74% | 4.10% | 1.88% | 0.25% | -4.28% | 2.76% | -5.49% | 5.35% | -0.50% | 6.00% | 24.28% |
Benchmark Metrics
GMO U.S. Equity Fund has an annualized alpha of -2.07%, beta of 0.92, and R2 of 0.80 versus S&P 500 Index. Calculated based on daily prices since January 02, 1990.
- This fund participated in 98.01% of S&P 500 Index downside but only 83.66% of its upside - more exposed to losses than it benefited from rallies.
- This fund had an annualized alpha of -2.07% versus S&P 500 Index - delivering less than market exposure alone would predict.
- With beta of 0.92 and R2 of 0.80, this fund moves broadly in line with S&P 500 Index - much of its variation is explained by market exposure rather than independent behavior.
- Alpha
- -2.07%
- Beta
- 0.92
- R²
- 0.80
- Upside Capture
- 83.66%
- Downside Capture
- 98.01%
Expense Ratio
GMUEX has an expense ratio of 0.47%, placing it in the medium range.
Return for Risk
Risk / Return Rank
GMUEX ranks 89 for risk / return — in the top 89% of mutual funds on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for GMO U.S. Equity Fund (GMUEX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GMUEX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.08 | ||
| Sortino ratioReturn per unit of downside risk | +1.37 | ||
| Omega ratioGain probability vs. loss probability | 1.50 | 1.32 | +0.18 |
| Calmar ratioReturn relative to maximum drawdown | 4.42 | 2.46 | +1.96 |
| Martin ratioReturn relative to average drawdown | 18.38 | 10.92 | +7.46 |
Dividends
Dividend History
GMO U.S. Equity Fund provided a 10.15% dividend yield over the last twelve months, with an annual payout of $1.70 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.70 | $1.70 | $2.32 | $1.57 | $0.84 | $2.09 | $1.24 | $1.61 | $2.53 | $1.73 | $1.64 | $1.86 |
Dividend yield | 10.15% | 11.68% | 17.31% | 12.10% | 6.99% | 14.17% | 9.16% | 12.24% | 21.90% | 11.22% | 11.27% | 12.88% |
Monthly Dividends
The table displays the monthly dividend distributions for GMO U.S. Equity Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.58 | $0.00 | $0.00 | $0.00 | $0.00 | $1.12 | $1.70 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.07 | $0.00 | $0.00 | $0.00 | $0.00 | $1.25 | $2.32 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.74 | $0.00 | $0.00 | $0.00 | $0.00 | $0.83 | $1.57 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.66 | $0.00 | $0.00 | $0.00 | $0.00 | $0.18 | $0.84 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.00 | $0.00 | $2.04 | $2.09 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the GMO U.S. Equity Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the GMO U.S. Equity Fund was 60.66%, occurring on Mar 9, 2009. Recovery took 1169 trading sessions.
The current GMO U.S. Equity Fund drawdown is 1.59%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Financial crisis2007–2009 | -60.66%Mar 2009 | 11y 8mo | 4y 7mo | 16y 4moJun 1997 - Oct 2013 |
COVID crash2020 | -33.90%Mar 2020 | 1mo 8d | 5mo 8d | 6mo 16dFeb 2020 - Aug 2020 |
Bear market2022 | -28.95%Sep 2022 | 9mo 24d | 1y 4mo | 2y 2moDec 2021 - Feb 2024 |
2025 selloff2025 | -20.85%Apr 2025 | 1mo 17d | 2mo 25d | 4mo 12dFeb 2025 - Jul 2025 |
Rate-hike selloffLate 2018 | -20.69%Dec 2018 | 10mo 29d | 6mo 9d | 1y 5moJan 2018 - Jul 2019 |
Drawdown Indicators
| GMUEX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -60.66% | -56.78% | -3.88% |
Max Drawdown (1Y)Largest decline over 1 year | -9.19% | -9.10% | -0.09% |
Max Drawdown (3Y)Largest decline over 3 years | -20.85% | -18.90% | -1.95% |
Max Drawdown (5Y)Largest decline over 5 years | -28.95% | -25.43% | -3.52% |
Max Drawdown (10Y)Largest decline over 10 years | -33.90% | -33.92% | +0.02% |
Current DrawdownCurrent decline from peak | -1.59% | -3.21% | +1.62% |
Average DrawdownAverage peak-to-trough decline | -17.23% | -10.71% | -6.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.20% | 2.04% | +0.16% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with GMUEX
Add GMO U.S. Equity Fund to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with GMUEX